You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDANot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF PHENOTYPIC CARDIOTOXICITY SCREENING WITH HUMAN D HEART TISSUES
SBC: Invivosciences, Inc. Topic: NIDANot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF Development of a Novel Technology Platform for the Rapid Detection of Cell Free Methylated DNA
SBC: Poointcare Genomics Corporation Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT
SBC: Pro-Change Behavior Systems, Inc. Topic: NCINot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF RD THERAPEUTIC DELIVERY OF ADP RIBOSYLARGININE HYDROLASE SBIR TOPIC PHASE I
SBC: PROTEIN FOUNDRY, LLC Topic: NHLBINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF FY IWIN NAVIGATING YOUR PATH TO WELL BEING SBIR PHASE II BASE AWARD PERIOD OF PERFORMANCE
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDANot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.
SBC: LUCIGEN CORPORATION Topic: 172DESCRIPTION provided by applicant The human transcriptome is significantly more complex than its cognate genome due to the hundreds of thousands of possible isoforms allele specific expression issues variable RNA editing changes and differential expression patterns spanning cell types developmental stages and physiological stresses Next generation sequencing NGS platforms are fundame ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Biological treatment of bacterial keratitis
SBC: AMEBAGONE INC Topic: NDESCRIPTION provided by applicant Staphylococcus is the most common cause of infections worldwide The pathogen persists asymptomatically on human skin from which it may spread to ocular tissues and cause corneal infection When this happens corneal bacterial keratitis can occur and if not treated effectively it may lead to blindness Multi Drug Resistant MDR variants of S aureus Sa are ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Neuroimaging tools for presurgical brain mapping
SBC: PRISM CLINICAL IMAGING INC Topic: 102DESCRIPTION provided by applicant The goal of this project is to develop functional magnetic resonance imaging fMRI tools to assist the diagnosis and treatment of human patients with a brain tumor or other operable pathology The specific focus of this proposal is to produce a practical clinic ready suite of MR imaging methods analyses and display tools to solve the number one impediment to ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
SBC: Bellbrook Labs, LLC Topic: 106DESCRIPTION provided by applicant Neurodegenerative diseases that affect motor neurons such as PD ALS and HD represent an enormous unmet medical need that is growing with the aging population Existing treatments have little or no effect on the course of disease and patients have to cope with the loss of brain and body function for the rest of their lives Defects in the transport of organell ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
